These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26660342)

  • 1. Subclinical very late thrombus formation inside and outside the everolimus-eluting stent implanted 3 years prior in a patient with provoked coronary spasms.
    Ito S; Ohmori H
    Cardiovasc Interv Ther; 2017 Jan; 32(1):72-76. PubMed ID: 26660342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late stent thrombosis of a second-generation drug- eluting stent.
    Karjalainen PP; Nammas W; Ylitalo A
    J Invasive Cardiol; 2012 Oct; 24(10):E225-7. PubMed ID: 23043049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary CT Angiography for In-Stent Restenosis: Diagnosis and Therapeutic Planning.
    Rozado J; Pascual I; Martín M; Calvo J; Avanzas P; Morís C
    J Invasive Cardiol; 2017 Jun; 29(6):E71. PubMed ID: 28570241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abluminal Neointimal Healing by Optical Coherence Tomography Assessment After Drug-Eluting Stent Implantation on Organized Recanalized Thrombus.
    Camacho Freire SJ; Limpo B; León Jiménez J; Gómez Menchero AE; Roa Garrido J; Cardenal Piris R; Díaz Fernández JF
    J Invasive Cardiol; 2017 Nov; 29(11):E161-E162. PubMed ID: 29086734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Artery Aneurysm After Bioresorbable Scaffold Implantation in a Woman With an Acute Coronary Syndrome.
    Cereda AF; Canova PA; Oreglia JA; Soriano FS
    J Invasive Cardiol; 2017 Jul; 29(7):E77-E78. PubMed ID: 28667808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report.
    Shibutani H; Akita Y; Matsui Y; Yoshinaga M; Karakawa M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):236. PubMed ID: 27887648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
    von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K
    Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary spasm-induced acute myocardial infarction associated with intracoronary thrombosis].
    Hasegawa A; Horimoto M; Takenaka T; Igarashi K
    Kokyu To Junkan; 1992 Feb; 40(2):189-93. PubMed ID: 1565886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
    Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G
    Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment.
    Mullen L; Khand A
    Can J Cardiol; 2016 Jun; 32(6):830.e9-830.e10. PubMed ID: 26514750
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy.
    Kagawa Y; Shiode N; Kawase T; Tamekiyo H; Okimoto T; Hayashi Y
    Cardiovasc Interv Ther; 2017 Apr; 32(2):170-173. PubMed ID: 26979600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.